Photodynamic therapy for superficial bladder cancer under local anaesthetic

BJU International

Volumn 89, Issue 7, 2002, Pages 665-670

  Shackley, D C ^a,b,c   Briggs, C ^a,b   Gilhooley, A ^a   Whitehurst, C ^b   O'Flynn, K J ^a   Betts, C D ^a   Moore, J V ^b   Clarke, N W ^a  

^a HOPE HOSPITAL   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

ALA; Bladder cancer; EMDA; Local anaesthetic; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; LIDOCAINE;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BLADDER FUNCTION; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DIFFUSION; DRUG EFFECT; DRUG POTENCY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; LOCAL ANESTHESIA; MALE; MUSCLE SPASM; PAIN; PAIN ASSESSMENT; PHASE 1 CLINICAL TRIAL; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; ANESTHESIA, LOCAL; ANESTHETICS, LOCAL; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; LIDOCAINE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PAIN; PAIN MEASUREMENT; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; URINARY BLADDER NEOPLASMS;

EID: 0036228699     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2002.02743.x     Document Type: Article

References (38)

1. Hematoporphyrin derivative. A possible aid in the diagnosis and therapy of carcinoma of the bladder
2. Whole bladder wall photoradiation therapy for carcinoma in situ of the bladder: A preliminary report
3. Photodynamic therapy (PDT) in the treatment of patients with resistant superficial bladder cancer: A long-term experience
4. Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional-cell carcinoma of the bladder
5. Clinical laser photodynamic therapy in the treatment of bladder carcinoma
6. Long-term experience with integral photodynamic therapy of TIS bladder carcinoma
7. Treatment of bladder cancer with hematoporphyrin derivatives and laser light
8. Complications of whole bladder dihematoporphyrin ether photodynamic therapy
9. Photodynamic therapy Tis and T1 transitional carcinoma of the bladder
10. Integral laser photodynamic treatment of refractory multifocal bladder tumors
11. Downstaging of BCG resistant CIS of the bladder by PDT with intravesical diffusion medium
12. Two years' experience with photodynamic therapy of bladder carcinoma
13. Whole bladder wall photodynamic therapy for refractory carcinoma in situ of the bladder
14. Long-term results of whole bladder wall photodynamic therapy for carcinoma in situ of the bladder
15. Integral photodynamic treatment of refractory superficial bladder cancer
16. Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma in situ of the bladder
17. Photoradiation therapy of bladder tumors
18. Photodynamic therapy in the management of resistant bladder cancer
19. Phase I trial of photodynamic therapy in the treatment of recurrent superficial transitional cell carcinoma of the bladder
20. Photodynamic therapy on rat urinary bladder with intravesical instillation of 5-aminolevulinic acid: Light diffusion and histological changes
21. Early clinical experience with 5-aminolaevulinic acid for the photodynamic therapy of superficial bladder cancer
22. Initial evaluation of whole bladder wall photodynamic therapy after intravesical ALA sensitisation for carcinoma-in-situ of the bladder
23. Electromotive diffusion (EMD) and photodynamic therapy with delta-aminolaevulinic acid (delta-ALA) for superficial bladder cancer
24. 5-Aminolevulinic acid-based photodynamic therapy. Principles and experimental research
25. Urodynamic changes during therapeutic intravesical instillations of capsaicin
26. Intravesical electromotive drug administration technique. Preliminary results and side effects
27. Plasma lignocaine concentration following nebulization for awake intubation
28. Cellular aspects of PDT for cancer
29. Photodynamic therapy and endothelial cells
30. Phthalocyanine photodynamic therapy. Disparate effects of pharmacologic inhibitors on cutaneous photosensitivity and on tumor regression
31. Biodistribution of Photofrin II and 5-aminolevulinic acid-induced protoporphyrin IX in normal rat bladder and bladder tumor models: Implications for photodynamic therapy
32. Biodistribution of protoporphyrin IX in rat urinary bladder after intravesical instillation of 5-aminolevulinic acid
33. Quantitative studies of the kinetics of 5-aminolaevulinic acid-induced fluorescence in bladder transitional cell carcinoma
34. Fluorescence cystoscopy following intravesical instillation of 5-aminolevulinic acid: A new procedure with high sensitivity for detection of hardly visible urothelial neoplasias
35. Complications of Bacillus Calmette Guerin immunotherapy in 1278 patients with bladder cancer
36. When intravesical measures fail. Indications for cystectomy in superficial disease
37. Sequential whole bladder photodynamic therapy treatments: A pre-clinical study